The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix

International Journal of Pharmaceutics

Volumn 201, Issue 1, 2000, Pages 29-36

  Kim, Ji Eon ^a   Kim, Seung Ryul ^b   Lee, Sun Hee ^a   Lee, Chi Ho ^a   Kim, Dae Duk ^a  

^a Pusan National University   (South Korea)

^b LG Chemical Ltd   (South Korea)

Author keywords

Cefadroxil; Controlled release; Polymeric matrix; Polyurethane; Pore former

Indexed keywords

BIOMATERIAL; BOVINE SERUM ALBUMIN; CEFADROXIL; MACROGOL; MANNITOL; POLYMER; POLYURETHAN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CHANNEL GATING; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MIXTURE; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATRIX TABLET; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

BACTERIA; CEFADROXIL; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; MANNITOL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; POLYETHYLENE GLYCOLS; POLYURETHANES; SERUM ALBUMIN, BOVINE; SOLUBILITY;

EID: 0034658449     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00388-4     Document Type: Article

References (21)

1. Ander J.M. Mechanisms of inflammation and infection with implanted devices. Cardiovasc. Pathol. 2:1993;33S-41S.
2. Buck R.E., Price K.E. Cefadroxil, a new broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 11:1977;324-330.
3. Gebelein C.G., Carraher C.E., Foster V.R. Applied Bioactive Polymeric Materials. 1988;Plenum Press, New York.
4. Golomb G., Shipigelman A. Prevention of bacterial colonization on polyurethane in vitro by incorporated antibacterial agent. J. Biomed. Mater. Res. 25:1991;937-952.
5. Gristina A.G., Hobgood C.D., Webb L.X., Myrvik Q.M. Adhesive colonization of biomaterials and antibiotic resistances. Biomaterials. 8:1987;423-426.
6. Gristina A.G., Naylor P.T., Myrvik Q.M., Wagner W.D. Microbial adhesion to biomaterials. Szycher M. High Performance Biomaterials. 1991;143-154 Technomics Publishing Company.
7. Hartstein A.E., Patrick K.E., Jones S.R., Millerand M.J., Brant R.E. Comparison of pharmacological and antimicrobial properties of cefadroxil and cephalexin. Antimicrob. Agents Chemother. 12:1977;93-97.
8. Kennedy J.F., Barker S.A., Zamir A. Active insolubilized antibiotics based on cellulose-metal chelates. Antimicrob. Agents Chemother. 6:1974;777-782.
9. Kim D.D., Takeno M.M., Ratner B.D., Horbett T.A. Glow discharge plasma deposition (GDPD) technique for the local controlled delivery of hirudin from biomaterials. Pharm. Res. 15(5):1998;783-786.
10. Lelah M.D., Cooper S.L. Polyurethanes in Medicine. 1986;CRC Press, Boca Raton, FL.
11. Levy, R.J., Johnston, T.P., Sintov, A., Golomb, G., 1989. Controlled release implants for cardiovascular disease. Fourth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, USA, February 21-24.
12. Rhine W.D., Hsieh D.S.T., Langer R. Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J. Pharm. Sci. 69(3):1980;265-270.
13. Sampath L.A., Chowdhury N., Caraos L., Modak S.M. Infection resistance of surface modified catheters with either short-lived or prolonged activity. J. Hosp. Infect. 30:1995;201-210.
14. Sanders L.M., Kell B.A., McRae G.I., Whitehead G.W. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. J. Pharm. Sci. 75:1986;356-360.
15. Schierholz J.M., Steinhauser H., Rump A.F.E., Berkels R., Pulverer G. Controlled release of antibiotics from biomedical polyurethane: morphological and structural features. Biomaterials. 18:1997;839-844.
16. Sugarman S., Young E.J. Infections Associated with Prosthetic Devices. 1984;CRC Press, Boca Raton, FL.
17. Sung K.C., Han R.Y., Hu Y.P.O., Hsu L.R. Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition. Int. J. Pharm. 172:1998;17-25.
18. Szycher M. Biostability of polyurethane elastomers: a critical review. Sharma C.P., Szycher M. Blood Compatible Materials and Devices. 1991;Technomic Publishing Company, Lancaster.
19. Tenrisaver B., Santella P.J. Cefadroxil: a review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine. Drugs. 32:1986;1-16.
20. Uchida T., Goto S. Biopharmaceutical evaluation of sustained-release ethylcellulose microcapsules containing cefadroxil and cephradine using beagle dogs. Chem. Pharm. Bull. 36(6):1988;2135-2144.
21. Uchida T., Yastake T., Goto S. Utility of mixture if commercially available polymers as constituents of sustained-release microcapsules containing cefadroxil or theophylline. Chem. Pharm. Bull. 40(2):1992;463-466.